RxDoctor Payments Data

John Lane, MD

Vascular Surgery · San Diego, CANPI 1043390172

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $159,867 of the $211,701 with a category attached, or 75.5%. Endologix LLC accounts for 77.6% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $81,704 and has fallen 97.4% since, to $2,086 in 2025. Among vascular surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$211,701in general payments, 2019–2025

Across 543 payments — averaging $389.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endologix LLC$164K
  • Silk Road Medical, Inc.$15K
  • W. L. Gore & Associates, Inc.$11K
  • Musculoskeletal Transplant Foundation Inc.$9K
  • Cook Medical LLC$4K
  • Abbott$2K
  • plus $6K from 18 others
$113,478in research payments, 2019–2025

Across 23 payments — averaging $4933.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endologix LLC$84K
  • Microvention, Inc.$22K
  • Humacyte Global, Inc.$8K

What the payments were for

  • Consulting fees$159,86776%
  • Grants$1670%
  • Travel & lodging$19,5519%
  • Food & beverage$32,11615%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$211,701 in reported general payments places this provider in the 95th percentile of 519 vascular surgery providers in California.

See all vascular surgery providers in California

Medicare billing

Part B allowed, 2024
$52,393
Medicare patients
289
Services billed
484

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →